Abiomed Inc (ABMD): Michael R Minogue , President, CEO, Chairman of Abiomed Inc sold 63,744 shares on Sep 19, 2016. The Insider selling transaction was reported by the company on Sep 21, 2016 to the Securities and Exchange Commission. The shares were sold at $127.04 per share for a total value of $8,095,860.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Aug 17, 2016, Dorothy E Puhy (director) sold 5,160 shares at $123.94 per share price.On Aug 10, 2016, Michael G Howley (VP, Global Sales & Marketing) sold 17,853 shares at $119.27 per share price.Also, On Aug 3, 2016, Paul Thomas (director) sold 10,000 shares at $118.65 per share price.On Aug 3, 2016, Henri A Termeer (director) sold 25,866 shares at $118.70 per share price.
ABIOMED (ABMD) witnessed a volatile trading activity on Tuesday Sep 21, 2016 and eventually ended flat at 0.00% or 0 points without letting the bulls or bears take much advantage. The trading began at $126.07 and reached the intraday high at $126.45. The bulls started the profit booking and pushed the shares to intraday low of $124.89. The trading session was marked by a volume range of 2,47,596 shares exchanging hands. The 52-week high of the shares is $127.1 and the 52-week low is $67.805. The market cap of the company stands at $5,384 M and there are 4,30,34,341 shares in public circulation.
Abiomed Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company’s products include Impella 2.5 a percutaneous micro heart pump with an integrated motor and sensors; Impella CP which is primarily used by either interventional cardiologists to support patients in the catheter lab or by surgeons in the heart surgery suite; Impella 5.0 and Impella LD a percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP a percutaneous catheter-based axial flow pump that is designed to allow greater than four liters of flow per minute; AB5000 a circulatory support system for the temporary support of acute heart failure patients in profound shock and Symphony a minimally invasive implantable cardiac assist device.